Totect Dosage
Generic name: DEXRAZOXANE HYDROCHLORIDE 500mg
Dosage form: injection, powder, lyophilized, for solution
Drug class: Miscellaneous uncategorized agents
Medically reviewed by Drugs.com. Last updated on Jul 30, 2024.
2.1 Recommended Dose for Extravasation
Reconstitute and further dilute Totect before use.
For extravasation, administer Totect via intravenous infusion over 1 to 2 hours once daily for 3 consecutive days. Initiate the first infusion as soon as possible and within the first six hours after extravasation.
The individual dosage is based on calculation of the Body Surface Area (BSA) up to a maximum dose of 2000 mg (each on Day 1 and 2) and 1000 mg (Day 3), corresponding to a BSA of 2 m2.
The recommended dose is: Maximum daily dose:
Day one: 1000 mg/m2 2000 mg
Day two: 1000 mg/m2 2000 mg
Day three: 500 mg/m2 1000 mg
2.2 Recommended Dose for Cardiomyopathy
Reconstitute and further dilute Totect before use.
For cardiomyopathy, administer Totect via intravenous infusion over 15 minutes prior to doxorubicin administration until discontinuation of doxorubicin. Do not administer via an intravenous push.
The recommended dosage ratio of Totect to doxorubicin is 10:1 (e.g., 500 mg/m2 Totect to 50 mg/m2 doxorubicin). Administer doxorubicin within 30 minutes after the completion of Totect infusion.
2.3 Dose Modifications
Dosing in Patients with Renal Impairment
Reduce the Totect dose by 50% in patients with creatinine clearance values < 40 mL/min.
Dosing in Patients with Hepatic Impairment
In patients with anthracycline extravasation, treatment with Totect is not recommended. In patients receiving dexrazoxane for cardiomyopathy, reduce the Totect dosage proportionately (maintaining the 10:1 ratio) in patients with hepatic impairment, since a doxorubicin dose reduction is recommended in the presence of hyperbilirubinemia.
Preparation
Read this entire section carefully before mixing and diluting.
Use caution when handling and preparing the reconstituted solution. The use of gloves is recommended. If Totect powder or solutions contact the skin or mucosae, wash exposed area immediately and thoroughly with soap and water. Follow special handling and disposal procedures.1
Totect should not be mixed or administered with any other drug during the infusion. The prepared solution of Totect is slightly yellow.
Parenteral drug products should be inspected visually for particulate matter prior to administration, whenever solution and container permit. Solutions containing a precipitate should be discarded. Vials are for single use only. Unused solution should be discarded.
Preparation for the Treatment of Extravasation
Step 1. Reconstitute each Totect vial with 50 mL of Sterile Water for Injection, USP. Once reconstituted, the reconstituted Totect solution contains 10 mg/mL of Totect.
Step 2. Calculate the volume of the 10 mg/mL reconstituted Totect solution needed for the recommended dose. In order to obtain the required dose, more than one vial may be needed. The reconstituted solution should be further diluted within 30 minutes after initial reconstitution. It contains no antibacterial preservative.
Step 3. Withdraw the calculated volume from the reconstituted Totect solution and further dilute into an infusion bag containing 1000 mL of Lactated Ringer’s Injection. Do not mix Totect with any other drugs.
Use the Totect infusion bag immediately after preparation. If not used immediately, the product is stable for 4 hours from the time of preparation when stored at room temperature or for up to 12 hours when stored refrigerated between 2ºC to 8ºC (36°F to 46°F).
Preparation for Reducing the Incidence and Severity of Cardiomyopathy
Step 1. Reconstitute each Totect vial with 50 mL of Sterile Water for Injection, USP. Once reconstituted, the reconstituted Totect solution contains 10 mg/mL of Totect.
Step 2. Calculate the volume of the 10 mg/mL reconstituted Totect solution needed for the recommended dose. In order to obtain the required dose, more than one vial may be needed. The reconstituted solution should be further diluted within 30 minutes after initial reconstitution. It contains no antibacterial preservative.
Step 3. Withdraw the calculated volume from the reconstituted Totect solution and further dilute to a concentration of 1.3 to 3 mg/mL in Lactated Ringer’s Injection. Do not mix Totect with any other drugs.
Use the Totect infusion solution immediately after preparation. If not used immediately, the product is stable for 4 hours from the time of preparation when stored at room temperature or for up to 12 hours when stored refrigerated between 2ºC to 8ºC (36°F to 46°F).
The infusion solutions have a pH of 3.5 to 5.5.
Administration
Do not administer or mix Totect with any other drugs during the infusion.
Administration for Treatment of Extravasation
Remove cooling procedures such as ice packs, if used, from the extravasation area at least 15 minutes before Totect administration in order to allow sufficient blood flow to the area of extravasation.
Administer the final diluted solution of Totect as an intravenous infusion over 1 to 2 hours at room temperature and normal light conditions in a large caliber vein in an extremity/area other than the one affected by the extravasation.
Treatment on Day 2 and Day 3 should start at the same hour (+/- 3 hours) as on the first day.
Perform local examination for extravasation on a regular basis after treatment and until resolution.
If vesicant compounds other than anthracyclines are being used through the same intravenous access, (e.g. vincristine, mitomycin, and vinorelbine), consider treatments for these other vesicant compounds. Totect is not effective against the effects of vesicants other than anthracyclines.
Administration for Reducing the Incidence and Severity of Cardiomyopathy
Administer the final diluted solution of Totect by intravenous infusion over 15 minutes before the administration of doxorubicin.
Do not administer via an intravenous push.
Administer doxorubicin within 30 minutes after the completion of Totect infusion.
Do not use Totect with non-anthracycline chemotherapy regimens.
More about Totect (dexrazoxane)
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.